These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29389581)

  • 21. Separation and characterization of forced degradation products of abacavir sulphate by LC-MS/MS.
    Rao RN; Vali RM; Ramachandra B; Raju SS
    J Pharm Biomed Anal; 2011 Jan; 54(2):279-85. PubMed ID: 20869185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of stress degradation products of febuxostat employing ultra-performance liquid chromatography-ultraviolet/photodiode array and liquid chromatography-mass spectrometry/time-of-flight studies.
    Saha M; Bali A; Patra SR; Singh J
    Rapid Commun Mass Spectrom; 2023 Jan; 37(2):e9423. PubMed ID: 36278931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and identification of cyclic imide and deamidation products in heat stressed pramlintide injection drug product.
    Hekman CM; DeMond WS; Kelley PJ; Mauch SF; Williams JD
    J Pharm Biomed Anal; 1999 Sep; 20(5):763-72. PubMed ID: 10701984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of urapidil stress degradation products by LC-Q-TOF-MS and NMR: Toxicity prediction of degradation products.
    Velip L; Dhiman V; Kushwah BS; Golla VM; Gananadhamu S
    J Pharm Biomed Anal; 2022 Mar; 211():114612. PubMed ID: 35101803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of forced degradation products of vortioxetine by LC/MS/MS and NMR.
    Ragi NC; Velma GR; Pallerla PK; Siddiqua S; Alugonda V; Rachamalla HKR; Pabbaraja S; Sripadi P
    J Pharm Biomed Anal; 2020 Sep; 188():113442. PubMed ID: 32622114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of degradation products of tegoprazan by LC-MS and GC-MS.
    Guo K; He X; Zhao H; Ma C
    J Pharm Biomed Anal; 2023 May; 228():115323. PubMed ID: 36921447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degradation kinetics study of cabozantinib by a novel stability-indicating LC method and identification of its major degradation products by LC/TOF-MS and LC-MS/MS.
    Wu C; Xu X; Feng C; Shi Y; Liu W; Zhu X; Zhang J
    J Pharm Biomed Anal; 2014 Sep; 98():356-63. PubMed ID: 24992215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of major degradation products of Eprinomectin drug substance including degradation pathways using LC-HRMS and NMR.
    Adhikari S; Rustum AM
    J Pharm Biomed Anal; 2022 Jun; 215():114767. PubMed ID: 35447491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LC-MS/MS studies for identification and characterization of new forced degradation products of dabrafenib and establishment of their degradation pathway.
    Grover P; Bhardwaj M; Mehta L
    J Pharm Biomed Anal; 2021 Nov; 206():114351. PubMed ID: 34509659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LC-MS/MS studies of ritonavir and its forced degradation products.
    Rao RN; Ramachandra B; Vali RM; Raju SS
    J Pharm Biomed Anal; 2010 Dec; 53(4):833-42. PubMed ID: 20619992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive study on degradation profile of firocoxib and structural elucidation of its key degradation products.
    Adhikari S; Tian J; Rustum AM
    J Pharm Biomed Anal; 2023 Feb; 224():115192. PubMed ID: 36463770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LC-MS/MS method for the characterization of the forced degradation products of Entecavir.
    Ramesh T; Rao PN; Rao RN
    J Sep Sci; 2014 Feb; 37(4):368-75. PubMed ID: 24323372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Separation, identification and characterization of stress degradation products of bortezomib using HPLC and LC-MS.
    Purushotham Reddy C; Ramakrishna K; Narayana Rao K
    Eur J Mass Spectrom (Chichester); 2021 Apr; 27(2-4):115-125. PubMed ID: 33827302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
    Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
    Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of degradation products of celiprolol hydrochloride using hyphenated mass and NMR techniques.
    Sahu A; Balhara A; Raju N; Kumar BK; Sharma P; Singh DK; Singh S
    J Pharm Biomed Anal; 2021 Apr; 197():113953. PubMed ID: 33618130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of a LC-MS/MS Method for the Profiling of Impurities Formed during Stress Study of Antifungal Agent-Efinaconazole.
    Govindarajan S; Asharani IV
    J Chromatogr Sci; 2022 Apr; 60(4):324-335. PubMed ID: 34160008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
    Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
    J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development.
    Stolarczyk EU; Rosa A; Kubiszewski M; Zagrodzka J; Cybulski M; Kaczmarek Ł
    Eur J Pharm Sci; 2017 Nov; 109():389-401. PubMed ID: 28865686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Column liquid chromatography-ultraviolet and column liquid chromatography/mass spectrometry evaluation of stress degradation behavior of escitalopram oxalate.
    Dhaneshwar SR; Mahadik MV; Kulkarni MJ
    J AOAC Int; 2009; 92(1):138-47. PubMed ID: 19382571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
    Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
    J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.